News Archive - Clexio

event-image

5 December 2024

Clexio announces 50% enrollment milestone reached in SOLEO study, a Phase 2 study assessing the safety and efficacy of CLE-100 as an adjunctive treatment in subjects with Major Depressive Disorder who have had inadequate response to standard antidepressant therapies

READ MORE

event-image

15 April 2024

Clexio Biosciences expands its protection of CLE-100 with the issuance of a third US method of use patent and the allowance of an additional three US patents

event-image

10 April 2024

Clexio initiates enrolment in SOLEO Study, a Phase 2 study assessing the safety and efficacy of CLE-100 as an adjunctive treatment in subjects with Major Depressive Disorder

READ MORE

event-image

4 April 2024

Clexio presents CLEO trial results at Oxford Conference on Ketamine and Related Compounds

READ MORE

event-image

15 January 2024

Clexio Biosciences receives second US method of use patent for CLE-100

event-image

15 May 2023

Clexio presents results of CLEO study “A Phase 2 Randomized Controlled Adjunctive Treatment Trial With CLE-100 Esketamine Tablet in Patients with Major Depressive Disorder (MDD) with Inadequate Response to Antidepressants” at American Society of Clinical Psychopharmacology Annual Meeting (ASCP 2023)

READ MORE

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Others